Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With...

Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment
With CyberKnife Radiosurgery for Prostate Cancer
September is Prostate Cancer Awareness Month

MIAMI and PALM BEACH, Fla., Sept. 2 /PRNewswire/ -- September is Prostate
Cancer Awareness Month, and the CyberKnife Centers of Miami and Palm Beach
announce a revolutionary new way to treat prostate cancer without surgery and
long treatment courses of radiation. Prostate cancer is the most common form
of cancer affecting men in the US.
Morse CyberKnife CEO, James G. Schwade, M.D., says, "for many cases that
are diagnosed early on, CyberKnife radiosurgery may be highly effective
without invasive, debilitating surgery or long courses of radiation."
CyberKnife is image guided robotic radiosurgery that precisely targets a
lesion or tumor and delivers an intense dose of radiation to a very small area
killing the cancer cells within. The CyberKnife treats prostate cancer in
the following manner:
-- Outpatient status
-- Non-invasive
-- Less pain and side effect than most alternatives
-- Complete treatment in 3-5 visits, each usually no longer than 1.5 hrs
-- Minimum radiation to surrounding normal areas

It is the mission of the Morse CyberKnife Centers to make the technology
an option available to all cancer patients who might benefit. For more
information please visit www.morsecyberknife.com or call 1-800-279-2900.
SOURCE Morse CyberKnife

Susan Nefzger, Susan Nefzger PR & Web Marketing, +1-561-632-9525, for Morse
CyberKnife